Vaxcyte

PCVX

Market cap $5.98B

45.66 USD

+2.74

6.38%

At close Updated Nov 11, 4:00 PM EST

Pre-market

After hours

45.66

0.00

1 day

6.38%

5 days

11.58%

1 month

4.22%

3 months

53.89%

6 months

44.54%

Year to date

-45.19%

1 year

-55.94%

5 years

24.82%

10 years

74.61%

About: Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Employees: 414

Healthcare Biotechnology